Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1213 ARTÍCULOS , VIENDO DEL 1021 AL 1035

The Use of Visual Analog Scales to Compare Pain Between Patients With Alzheimer's Disease and Patients Without Any Known Neurodegenerative Disease and Their Caregivers

Santos S, Castanho M.

Am J Alzheimers Dis Other Demen. 2014 Jun;29(4):320-5. doi: 10.1177/1533317513517046. Epub 2013 Dec 26.

Brain metabolic dysfunction at the core of Alzheimer's disease

de la Monte SM, Tong M.

Biochem Pharmacol. 2014 Apr 15;88(4):548-59. doi: 10.1016/j.bcp.2013.12.012. Epub 2013 Dec 28.

Comparison between PET template-based method and MRI-based method for cortical quantification of florbetapir (AV-45) uptake in vivo

Saint-Aubert L, Nemmi F, Péran P, Barbeau EJ, Payoux P, Chollet F, Pariente J.

Eur J Nucl Med Mol Imaging. 2014 May;41(5):836-43. doi: 10.1007/s00259-013-2656-8. Epub 2013 Dec 19.

Voxelwise multivariate analysis of multimodality magnetic resonance imaging

Naylor MG, Cardenas VA, Tosun D, Schuff N, Weiner M, Schwartzman A.

Hum Brain Mapp. 2014 Mar;35(3):831-46. doi: 10.1002/hbm.22217. Epub 2013 Feb 13.

The ε4 genotype of apolipoprotein E and white matter integrity in Alzheimer's disease

Kljajevic V, Meyer P, Holzmann C, Dyrba M, Kasper E, Bokde AL, Fellgiebel A, Meindl T, Hampel H, Teipel S; EDSD study group.

Alzheimers Dement. 2014 May;10(3):401-4. doi: 10.1016/j.jalz.2013.02.008. Epub 2013 May 21.

Mitochondrial DNA deletions in Alzheimer's brains: a review

Phillips NR, Simpkins JW, Roby RK.

Alzheimers Dement. 2014 May;10(3):393-400. doi: 10.1016/j.jalz.2013.04.508. Epub 2013 Jul 11.

The potential mechanisms of Aβ-receptor for advanced glycation end-products interaction disrupting tight junctions of the blood-brain barrier in Alzheimer's disease

Wan W, Chen H, Li Y.

Int J Neurosci. 2014 Feb;124(2):75-81. doi: 10.3109/00207454.2013.825258. Epub 2013 Aug 15.

ATP5H/KCTD2 locus is associated with Alzheimer's disease risk

Boada M, Antúnez C, Ramírez-Lorca R, DeStefano AL, González-Pérez A, Gayán J, López-Arrieta J, Ikram MA, Hernández I, Marín J, Galán JJ, Bis JC, Mauleón A, Rosende-Roca M, Moreno-Rey C, Gudnasson V, Morón FJ, Velasco J, Carrasco JM, Alegret M, Espinosa A, Vinyes G, Lafuente A, Vargas L, Fitzpatrick AL; Alzheimer’s Disease Neuroimaging Initiative; Launer LJ, Sáez ME, Vázquez E, Becker JT, López OL, Serrano-Ríos M, Tárraga L, van Duijn CM, Real LM, Seshadri S, Ruiz A.

Mol Psychiatry. 2014 Jun;19(6):682-7. doi: 10.1038/mp.2013.86. Epub 2013 Jul 16.

Microglia, neuroinflammation, and beta-amyloid protein in Alzheimer's disease

Cai Z, Hussain MD, Yan LJ.

Int J Neurosci. 2014 May;124(5):307-21. doi: 10.3109/00207454.2013.833510. Epub 2013 Sep 12.

Pathological roles of ceramide and its metabolites in metabolic syndrome and Alzheimer's disease

Yuyama K, Mitsutake S, Igarashi Y.

Biochim Biophys Acta. 2014 May;1841(5):793-8. doi: 10.1016/j.bbalip.2013.08.002. Epub 2013 Aug 13.

Association between Alzheimer's disease and the NOS3 gene Glu298Asp polymorphism

Hua Y, Zhao H, Kong Y, Lu X.

Int J Neurosci. 2014 Apr;124(4):243-51. doi: 10.3109/00207454.2013.834336. Epub 2013 Sep 23.

Dysfunctional synapse in Alzheimer's disease - A focus on NMDA receptors

Mota SI, Ferreira IL, Rego AC.

Neuropharmacology. 2014 Jan;76 Pt A:16-26. doi: 10.1016/j.neuropharm.2013.08.013. Epub 2013 Aug 22.

Evaluation of common structural brain changes in aging and Alzheimer disease with the use of an MRI-based brain atrophy and lesion index: a comparison between T1WI and T2WI at 1.5T and 3T

Guo H, Song X, Vandorpe R, Zhang Y, Chen W, Zhang N, Schmidt MH, Rockwood K; Alzheimer's Disease Neuroimaging Initiative.

AJNR Am J Neuroradiol. 2014 Mar;35(3):504-12. doi: 10.3174/ajnr.A3709. Epub 2013 Aug 29.

Positive and negative effects of prostaglandins in Alzheimer's disease

Fattahi MJ, Mirshafiey A.

Psychiatry Clin Neurosci. 2014 Jan;68(1):50-60. doi: 10.1111/pcn.12092. Epub 2013 Sep 2.

Alzheimer's disease in the human eye. Clinical tests that identify ocular and visual information processing deficit as biomarkers

Chang LY, Lowe J, Ardiles A, Lim J, Grey AC, Robertson K, Danesh-Meyer H, Palacios AG, Acosta ML.

Alzheimers Dement. 2014 Mar;10(2):251-61. doi: 10.1016/j.jalz.2013.06.004. Epub 2013 Sep 5.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias